Clinical Trials

Heart disease study in patients with type 2 diabetes

Posted on 7/25/2019

This study is being done to assess whether the type 2 diabetes medicine, semaglitide, has a positive effect on heart disease.  This will be done by comparing it to placebo (no active ingredients).  This will be an oral tablet taken daily in the morning on an empty stomach.

You may qualify for this study if you:
  • Have type 2 diabetes
  • Have or had heart disease, certain diseases of the arteries and /or kidney disease
  • Are at least 50 years of age 

The study duration is approximately 3-5 years.  There will be 25 visits to the clinic, however after the first 3 months, you will only come to the clinic every 3 months.

There will be no charge for participating in the study.  The study medication, study materials and study specific visits will be provided at no charge to you or your insurance company. 

If you qualify and decide to participate you will be compensated for your time and travel while participating in the study.  

You will receive $50 for each study visit for a total of up to $1,300.

Call our office for more information - (903) 238-8854
What Our Research Patients are Saying
Being able to participate in the COPD research study has been a life changing event for me.  This is an ongoing positive experience that has already made major differences in my health and the quality of my life. 
 
At the initial interview I was met by a team of friendly, caring, extremely knowledgeable and professional staff.  The high level of care and concern extended to me by the research doctor and everyone involved in this research study is phenomenal.  The research coordinator who I’ve been assigned to is simply “The Best”.  She answers and explains every question I have, she listens when I am having problems with my COPD, and offers helpful suggestions to get me through the rough spots.  She cheers me on when I need it most and follows up with phone calls to make certain I’m ok afterwards.
 
I’m amazed with the positive changes in my health from the first month of my participation. To cough is a rare occurrence where previously it was chronic…all day, every day.   Just walking short distances would render me breathless.  I now can walk longer, do more physically, and breathe much better.  I’m also not so tired all the time.  What a welcome change!
 
I’m happier, less fearful, and more confident in coping with COPD as a result of this research program.  If my participation can contribute to helping others cope with COPD that would be the absolutely ultimate outcome for me.  Thank you for allowing me this opportunity.     
~ S.T.

Contact Form


  
DCOL of Longview